tiprankstipranks
Trending News
More News >
Oxford BioDynamics PLC (GB:OBD)
LSE:OBD

Oxford BioDynamics (OBD) Stock Statistics & Valuation Metrics

Compare
34 Followers

Total Valuation

Oxford BioDynamics has a market cap or net worth of £10.08M. The enterprise value is 3.72M.
Market Cap£10.08M
Enterprise Value3.72M

Share Statistics

Oxford BioDynamics has 4,290,911,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,290,911,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Oxford BioDynamics’s return on equity (ROE) is -9.99 and return on invested capital (ROIC) is -153.84%.
Return on Equity (ROE)-9.99
Return on Assets (ROA)-1.38
Return on Invested Capital (ROIC)-153.84%
Return on Capital Employed (ROCE)-1.95
Revenue Per Employee21.47K
Profits Per Employee-218.69K
Employee Count51
Asset Turnover0.14
Inventory Turnover37.15

Valuation Ratios

The current PE Ratio of Oxford BioDynamics is ―. Oxford BioDynamics’s PEG ratio is 0.00718.
PE Ratio
PS Ratio6.02
PB Ratio5.90
Price to Fair Value5.90
Price to FCF-0.85
Price to Operating Cash Flow-0.26
PEG Ratio0.00718

Income Statement

In the last 12 months, Oxford BioDynamics had revenue of 1.09M and earned -11.15M in profits. Earnings per share was -0.01.
Revenue1.09M
Gross Profit-6.15M
Operating Income-10.66M
Pretax Income-11.42M
Net Income-11.15M
EBITDA-9.80M
Earnings Per Share (EPS)-0.01

Cash Flow

In the last 12 months, operating cash flow was -7.71M and capital expenditures -17.00K, giving a free cash flow of -7.73M billion.
Operating Cash Flow-7.71M
Free Cash Flow-7.73M
Free Cash Flow per Share>-0.01

Dividends & Yields

Oxford BioDynamics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.66
52-Week Price Change-79.49%
50-Day Moving Average0.31
200-Day Moving Average0.41
Relative Strength Index (RSI)32.06
Average Volume (3m)21.87M

Important Dates

Oxford BioDynamics upcoming earnings date is Jan 27, 2026, TBA (Confirmed).
Last Earnings DateDec 16, 2025
Next Earnings DateJan 27, 2026
Ex-Dividend Date

Financial Position

Oxford BioDynamics as a current ratio of 0.88, with Debt / Equity ratio of 457.97%
Current Ratio0.88
Quick Ratio0.80
Debt to Market Cap0.20
Net Debt to EBITDA-0.38
Interest Coverage Ratio-25.27

Taxes

In the past 12 months, Oxford BioDynamics has paid -269.00K in taxes.
Income Tax-269.00K
Effective Tax Rate0.02

Enterprise Valuation

Oxford BioDynamics EV to EBITDA ratio is -1.05, with an EV/FCF ratio of -1.33.
EV to Sales9.41
EV to EBITDA-1.05
EV to Free Cash Flow-1.33
EV to Operating Cash Flow-1.34

Balance Sheet

Oxford BioDynamics has £1.39M in cash and marketable securities with £5.11M in debt, giving a net cash position of -£3.72M billion.
Cash & Marketable Securities£1.39M
Total Debt£5.11M
Net Cash-£3.72M
Net Cash Per Share>-£0.01
Tangible Book Value Per Share<£0.01

Margins

Gross margin is -561.55%, with operating margin of -973.79%, and net profit margin of -1018.54%.
Gross Margin-561.55%
Operating Margin-973.79%
Pretax Margin-1043.11%
Net Profit Margin-1018.54%
EBITDA Margin-895.07%
EBIT Margin-1004.57%

Analyst Forecast

The average price target for Oxford BioDynamics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast72.17%
EPS Growth Forecast79.03%

Scores

Smart ScoreN/A
AI Score